Gilad Liberman

Gilad Liberman

Auto-generated profile, based on publicly available information

Gilad Liberman

Department of Chemical and Biological Physics, Weizmann Institute, Rehovot, Israel

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2013 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
GLGilad Liberman
Gilad Liberman
YLYoram Louzoun
Yoram Louzoun
DBDafna Ben Bashat
Dafna Ben Bashat

1 July 2014 in European Journal of Radiology
Verified
Journal Article
Closed access
MAMoran Artzi
Moran Artzi
FBFelix Bokstein
Felix Bokstein
DBDeborah T. Blumenthal
Deborah T. Blumenthal
OAOrna Aizenstein
Orna Aizenstein
GLGilad Liberman
Gilad Liberman
DBDafna Ben Bashat
Dafna Ben Bashat

24 February 2022 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
XCXiaozhi Cao
Xiaozhi Cao
CLCongyu Liao
Congyu Liao
SISiddharth Srinivasan Iyer
Siddharth Srinivasan Iyer
ZWZhixing Wang
Zhixing Wang
ZZZihan Zhou
Zihan Zhou
KSKawin Setsompop
Kawin Setsompop

6 April 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
DBD.T. Blumenthal
D.T. Blumenthal
MAM. Artzi
M. Artzi
GLG. Liberman
G. Liberman
FBF. Bokstein
F. Bokstein
OAO. Aizenstein
O. Aizenstein
DBD. Ben Bashat
D. Ben Bashat
BACKGROUND AND PURPOSE: Current imaging assessment of high-grade brain tumors relies on the Response Assessment in Neuro-Oncology criteria, which measure gross volume of enhancing and nonenhancing lesions from conventional MRI sequences. These assessments may fail to reliably distinguish tumor and nontumor. This study aimed to classify enhancing and nonenhancing lesion areas into tumor-versus-nontumor components. MATERIALS AND METHODS: A total of 140 MRI scans obtained from 32 patients with high-grade gliomas and 6 patients with brain metastases were included. Classification of lesion areas was performed using a support vector machine classifier trained on 4 components: enhancing and nonenhancing, tumor and nontumor, based on T1-weighted, FLAIR, and dynamic-contrast-enhancing MRI parameters. Classification results were evaluated by 2-fold cross-validation analysis of the training set and MR spectroscopy. Longitudinal changes of the component volumes were compared with Response Assessment in Neuro-Oncology criteria. RESULTS: Normalized T1-weighted values, FLAIR, plasma volume, volume transfer constant, and bolus-arrival-time parameters differentiated components. High sensitivity and specificity (100%) were obtained within the enhancing and nonenhancing areas. Longitudinal changes in component volumes correlated with the Response Assessment in Neuro-Oncology criteria in 27 patients; 5 patients (16%) demonstrated an increase in tumor component volumes indicating tumor progression. These changes preceded Response Assessment in Neuro-Oncology assessments by several months. Seven patients treated with bevacizumab showed a shift to an infiltrative pattern of progression. CONCLUSIONS: This study proposes an automatic classification method: segmented Response Assessment in Neuro-Oncology criteria based on advanced imaging that reliably differentiates tumor and nontumor components in high-grade gliomas. The segmented Response Assessment in Neuro-Oncology criteria may improve therapy-response assessment and provide earlier indication of progression.

1 January 2013 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
GLGilad Liberman
Gilad Liberman
JBJennifer Benichou
Jennifer Benichou
LTLea Tsaban
Lea Tsaban
JGJacob Glanville
Jacob Glanville
YLYoram Louzoun
Yoram Louzoun
Affinity maturation occurs through two selection processes: the choice of appropriate clones (clonal selection), and the internal evolution within clones, induced by somatic hyper-mutations, where high affinity mutants are selected for. When a final population of immunoglobulin sequences is observed, the genetic composition of this population is affected by a combination of these two processes. Different immune induced diseases can result from the failure of regulation of clonal selection or of the regulation of the within clone affinity maturation. In order to understand each of these processes separately, we propose a mixed lineage tree/sequence based method to detect within clone selection as defined by the effect of mutations on the average number of offspring. Specifically, we measure the imbalance in the number of leaves in lineage trees branches following synonymous and non-synonymous (NS) mutations. If a mutation is positively selected, we expect the number of leaves in the sub-tree below this mutation to be larger than in the parallel sub-tree without the mutation. The ratio between the number of leaves in such branches following NS mutations can be used to measure selection within a clone. We apply this method to the sampled Ig repertoire from multiple healthy volunteers and show that within clone selection is positive in the CDR2 region and either positive or negative in the CDR3 and FWR3 regions. Selection occurs already at the IgM isotype level mainly in the DH gene region, with a strong negative selection in the join region. This is followed in the later memory stages in the CDR2 region. We have not studied here the FWR1 and CDR1 regions. An important advantage of this method is that it is very weakly affected by the baseline mutation model or by sampling biases, as are most synonymous to NS mutations ratio based methods.

5 November 2014 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
MAMoran Artzi
Moran Artzi
DBDeborah T. Blumenthal
Deborah T. Blumenthal
FBFelix Bokstein
Felix Bokstein
GNGuy Nadav
Guy Nadav
GLGilad Liberman
Gilad Liberman
DBDafna Ben Bashat
Dafna Ben Bashat